CA2227425A1 - Therapie genique cellulaire - Google Patents

Therapie genique cellulaire Download PDF

Info

Publication number
CA2227425A1
CA2227425A1 CA002227425A CA2227425A CA2227425A1 CA 2227425 A1 CA2227425 A1 CA 2227425A1 CA 002227425 A CA002227425 A CA 002227425A CA 2227425 A CA2227425 A CA 2227425A CA 2227425 A1 CA2227425 A1 CA 2227425A1
Authority
CA
Canada
Prior art keywords
cells
gene
pulmonary
growth factor
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002227425A
Other languages
English (en)
Inventor
Duncan John Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
An Go Gen Inc
Original Assignee
An Go Gen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by An Go Gen Inc filed Critical An Go Gen Inc
Priority to CA002227425A priority Critical patent/CA2227425A1/fr
Priority to CA 2266805 priority patent/CA2266805C/fr
Publication of CA2227425A1 publication Critical patent/CA2227425A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/13—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen (1.14.13)
    • C12Y114/13039—Nitric-oxide synthase (NADPH dependent) (1.14.13.39)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002227425A 1998-03-27 1998-03-27 Therapie genique cellulaire Abandoned CA2227425A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002227425A CA2227425A1 (fr) 1998-03-27 1998-03-27 Therapie genique cellulaire
CA 2266805 CA2266805C (fr) 1998-03-27 1999-03-25 Therapie genique cellulaire dans le traitement des affections pulmonaires

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002227425A CA2227425A1 (fr) 1998-03-27 1998-03-27 Therapie genique cellulaire

Publications (1)

Publication Number Publication Date
CA2227425A1 true CA2227425A1 (fr) 1999-09-27

Family

ID=29409110

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002227425A Abandoned CA2227425A1 (fr) 1998-03-27 1998-03-27 Therapie genique cellulaire

Country Status (1)

Country Link
CA (1) CA2227425A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001021184A1 (fr) * 1999-09-23 2001-03-29 An-Go-Gen Inc. Therapie genique cellulaire pour le systeme pulmonaire
WO2004058293A1 (fr) * 2002-12-24 2004-07-15 Northern Therapeutics Inc. Procedes de diagnostic, de prevention et de traitement de l'apparition precoce de l'hypertension pulmonaire

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001021184A1 (fr) * 1999-09-23 2001-03-29 An-Go-Gen Inc. Therapie genique cellulaire pour le systeme pulmonaire
WO2004058293A1 (fr) * 2002-12-24 2004-07-15 Northern Therapeutics Inc. Procedes de diagnostic, de prevention et de traitement de l'apparition precoce de l'hypertension pulmonaire

Similar Documents

Publication Publication Date Title
US6482406B1 (en) Cell-based gene therapy for the pulmonary system
US9827270B2 (en) Cell-based therapy for the pulmonary system
US20210145894A1 (en) Cell-based therapy for the pulmonary system
US5792453A (en) Gene transfer-mediated angiogenesis therapy
US6174871B1 (en) Gene therapies for enhancing cardiac function
US20030118567A1 (en) Cell-based therapy for the pulmonary system
EA019099B1 (ru) Способ направленной доставки трансгена в миокард пациента с ишемией миокарда
CA2227425A1 (fr) Therapie genique cellulaire
EP1220679B1 (fr) Therapie genique cellulaire pour le systeme pulmonaire
JP3410738B2 (ja) ミクログリアからなる医薬用キャリアー
CA2578815A1 (fr) Support conditionne de cellules progenitrices autologues ou allogenes pour traitement de l'angiogenese
AU706050C (en) Gene transfer-mediated angiogenesis therapy
CN114984184A (zh) 增强tbx1表达在修复心脏组织损伤中的用途
AU4754199A (en) Gene transfer-mediated angiogenesis therapy
AU2006235836A1 (en) Gene transfer-mediated angiogenesis therapy

Legal Events

Date Code Title Description
FZDE Dead